Morgan Stanley’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,900
| Closed | -$39K | – | 8020 |
|
|
2022
Q3 | $39K | Hold |
3,900
| – | – | ﹤0.01% | 6524 |
|
|
2022
Q2 | $39K | Hold |
3,900
| – | – | ﹤0.01% | 6723 |
|
|
2022
Q1 | $38K | Hold |
3,900
| – | – | ﹤0.01% | 6839 |
|
|
2021
Q4 | $38K | Hold |
3,900
| – | – | ﹤0.01% | 6939 |
|
|
2021
Q3 | $38K | Hold |
3,900
| – | – | ﹤0.01% | 6837 |
|
|
2021
Q2 | $38K | Buy |
+3,900
| New | +$38K | ﹤0.01% | 6782 |
|